公开(公告)号：US10537579B2

公开(公告)日：2020-01-21

申请号：US15976135

申请日：2018-05-10

Applicant: JUNTENDO EDUCATIONAL FOUNDATION ,  KOWA COMPANY, LTD.

Inventor： Takenori Inomata ,  Toshinari Funaki

IPC: A61K31/551 ,  A61P27/02 ,  A61K9/08 ,  A61K9/00

Abstract: To provide a novel method for suppressing rejection after corneal transplantation.The method for suppressing rejection after corneal transplantation includes administering an effective amount of a Rho kinase inhibitor to a patient who needs it.

公开(公告)号：US20210116466A1

公开(公告)日：2021-04-22

申请号：US16500530

申请日：2018-04-04

Applicant: Renatech Co., Ltd. ,  Juntendo Educational Foundation

Inventor： Seiichi Inagaki ,  Naoyuki Okamoto ,  Takenori Inomata

IPC: G01N33/84 ,  G16H50/30 ,  G01N33/49

Abstract: An AMD risk evaluation method is provided. The concentrations of a set of evaluation elements contained in a serum sample 2 taken from a subject are measured (step S1), the concentration data of the set of evaluation elements thus measured are applied to a predetermined discriminant function to perform an operation (step S2); and whether or not the subject suffers from AMD is discriminated based on the operation result obtained by applying the concentration data to the discriminant function (step S3). The discrimination is carried out in accordance with the concentration balance (pattern) of the set of evaluation elements. The set of evaluation elements is designated by choosing all or part of specific elements that have the concentration data for both of the case group and the control group based on the discriminant abilities in arbitrary combinations of the specific elements.